Plasma Patents (Class 604/6.04)
-
Publication number: 20110208106Abstract: An ultrafiltration filter for an extracorporeal blood circuit having an input for blood withdrawn from a human patient and a blood output for filtered blood to be infused into the patient including: a filter body having a length of at least 20 centimeters (cm) and an interior diameter of no greater than 1.5 cm; an input at a first end of the body to receive the withdrawn blood; an output at a second end of the body to discharge the filtered blood; a filter membrane in the body defining a blood passage through the body, wherein the membrane has an active filter membrane surface area of no greater than 0.2 meters squared (m2) and the filter membrane blocks passage of blood molecules having a molecular weight cut of greater than 60,000 Daltons and a volume of the blood passage in the filter being less than two percent of a cardiac output of the patient, and an ultrafiltrate output to the body and open to a side of the filter surface area opposite to the blood passage.Type: ApplicationFiled: May 2, 2011Publication date: August 25, 2011Applicant: CHF SOLUTIONS, INC.Inventors: Howard R. Levin, Mark Gelfand, John O'Mahony, Hans-Dietrich Polaschegg
-
Patent number: 7879242Abstract: A method and a device to increase the efficiency of dialysis for the removal from blood of substances that are more or less tightly bound to carriers such as albumin. According to the invention this is accomplished by a simultaneous significant increase of the flow rate of the dialysis fluid and of the area of the membrane that separates the blood from the dialysis fluid, compared to conventional dialysis.Type: GrantFiled: September 28, 2009Date of Patent: February 1, 2011Assignee: Gambro Lundia ABInventors: Jan Sternby, Berit Sternby
-
Publication number: 20110009720Abstract: A portable continuous whole blood glucose monitor comprising, a mid-infrared quantum cascade laser and driver in optical communication with a transmission cell and a photo-conductive detector and pre-amplifier. The monitor further comprises a peristaltic pump connected to a single lumen catheter peripherally inserted into a patient's vein. The single lumen catheter, in combination with the peristaltic pump, is operable to automatically withdraw a fixed and metered amount of whole blood from a patient, then a tube delivers a fixed and metered amount of the saline/surfactant supply to the whole blood. Methods of enhancing measurement sensitivity are also provided.Type: ApplicationFiled: November 2, 2007Publication date: January 13, 2011Inventors: Kislaya Kunjan, Frank Perry Lloyd
-
Patent number: 7806845Abstract: This invention provides an apparatus and methods to consistently separate and concentrate selected blood components. The system includes, e.g., a computerized fluid handling system to transfer blood components between a centrifugal blood separation disc, containers and a concentrator.Type: GrantFiled: April 23, 2003Date of Patent: October 5, 2010Assignee: Biomet Biologics, LLCInventors: Douglas M. Arm, Michael Ponticiello, Surinder Mathur, Andrew G. Hood
-
Publication number: 20100234788Abstract: A method for the re-anticoagulation of platelet rich plasma in a blood apheresis system includes priming the blood apheresis system with anticoagulant, such that a volume of anticoagulant is transferred to a PRP container. The method may then transfer the anticoagulant within the PRP container to a red blood cell container, and collect a volume of platelet rich plasma within the PRP container. The platelet rich plasma may be collected in a plurality of cycles. Between collection cycles, the method may transfer a portion of the volume of anticoagulant from the red blood cell container to the PRP container.Type: ApplicationFiled: March 12, 2009Publication date: September 16, 2010Applicant: HAEMONETICS CORPORATIONInventors: Etienne Pages, Michael Ragusa
-
Patent number: 7794720Abstract: The present invention relates to isolated canine animal plasma, a method for isolating canine animal plasma, plasma obtained form an immunised or hyperimmunised canine animal and treating a canine animal with the isolated canine animal plasma. The method includes the step of selecting a canine animal having a blood group compatible with a recipient canine animal having an unmatched blood group, namely, selecting a canine animal for a blood group that does not cause plasma transfusion reaction and/or haemolysis. In one form, the method includes the step of immunising or hyperimmunising a canine animal plasma donor with one or more antigens of a canine animal pathogen. The pathogen is preferably a bacteria or virus.Type: GrantFiled: April 29, 2004Date of Patent: September 14, 2010Assignee: Plasma Ventures Pty LtdInventor: Ross Phillip Wilson
-
Patent number: 7780621Abstract: A blood chamber for an extracorporeal blood circuit comprises a blood inlet port (2), a blood containment chamber (3), a first conduit (8) which connects the blood inlet port (2) with the blood containment chamber (3) and which has an end tract (8a) that terminates in the blood containment chamber (3) with a horizontal inlet component. The first conduit (8) comprises a pre-terminal tract (8b) which precedes the end tract (8a) and which has at least a second horizontal component which is directed in an opposite direction to the horizontal inlet component. The blood chamber is used in an arterial line of a dialysis set for guaranteeing a regular and gentle blood flow.Type: GrantFiled: July 6, 2005Date of Patent: August 24, 2010Assignee: Gambro Lundia ABInventors: Robert Neri, Andrea Paltrinieri
-
Publication number: 20100185134Abstract: Artificial kidney for gradual, and at least semi-continuous, blood treatment, wherein a blood stream is fed from a body of a living human or animal being into the artificial kidney, where anticoagulation is first effected, blood cells and molecules of large and medium molecular weight, such as proteins, are then primarily separated from plasma and fed back to the blood stream, regulating a water and salt balance by diverting excess plasma water and further removing from the blood stream, plasma or plasma water accumulated and toxic substances, by removal of specific electrolytes and waste products and wherein purified or partially purified plasma and plasma water is being carried back to the blood tract of the body.Type: ApplicationFiled: June 16, 2008Publication date: July 22, 2010Applicant: Relitech B.V.Inventors: Franciscus Peter Houwen, Henk Van Middendorp, Jacobus Cornelis Musters
-
Publication number: 20100121246Abstract: An apparatus for carrying out selected fluid management and/or renal replacement patient therapy is characterized by an interactive operator control system having operator inputs for selectively changing a panel kit, replacing a filter cartridge, and/or changing to a different patient therapy during a currently running patient therapy, and providing operator instructions for carrying out tasks for completing same. In one embodiment, the interactive operator control system is also characterized by automatically serially identifying different setup steps to be carried out during system setup, displaying the successive steps substantially throughout the system setup as well as displaying on the operator interface screen sequential tasks to be carried out for each of the different setup steps.Type: ApplicationFiled: October 29, 2009Publication date: May 13, 2010Applicant: TRANSVIVO INC.Inventors: Harold Peters, Adam Heintzelman, Jacob Kearns, Tommy Cooper, Michael Delmage
-
Patent number: 7708710Abstract: Methods are disclosed for collecting and separating whole blood into one or more components. A disposable blood separation fluid circuit is provided which is adapted to cooperate with a reusable separation controller. The fluid circuit includes a fluid flow path for communication with a blood source and at least one container in fluid communication with the fluid flow path. The fluid flow path is connected to a blood source and quantities of whole blood are collected in the container and one other location within the fluid circuit. The source is then disconnected from the disposable fluid circuit. The quantities of whole blood are centrifugally processed, with processing of at least a portion of one of the quantities beginning after the source is disconnected from the fluid circuit.Type: GrantFiled: April 16, 2004Date of Patent: May 4, 2010Assignee: Fenwal, Inc.Inventors: Kyungyoon Min, Richard I. Brown
-
Patent number: 7686777Abstract: An in-vitro blood plasma lipids filtering method includes the following steps: separating out the blood plasma from the blood collection; flushing a filtering device with saline solution; controlling the pressure of the separated blood plasma; passing the blood plasma to the filtering device for filtering out lipids; controlling the temperature of the filtered blood plasma; and feeding the blood plasma back to the blood. The method is clearly effective and accurate, quick response indication, securer and safer, more tolerant, and the treatment time is short.Type: GrantFiled: February 28, 2005Date of Patent: March 30, 2010Assignee: Shanghai Jiangxia Blood Technology Co., Ltd.Inventors: Heping Huang, Siukwan Chang
-
Publication number: 20100042037Abstract: Method and apparatus for separating plasma from blood in a separation vessel and further separator the separated plasma into desired plasma proteins in a plasma separator fluidly connected to the separation vessel to receive the separated plasma.Type: ApplicationFiled: April 24, 2009Publication date: February 18, 2010Applicant: CARIDIANBCT, INC.Inventors: Thomas J. FELT, Frank CORBIN, III, Steven Gage URDAHL
-
Publication number: 20100042038Abstract: Method and apparatus for separating plasma from blood in a membrane separator and further separator the separated plasma into desired plasma proteins in a plasma separator fluidly connected to the membrane separator to receive the separated plasma.Type: ApplicationFiled: April 24, 2009Publication date: February 18, 2010Applicant: CaridianBCT, Inc.Inventors: Steven Gage URDAHL, Frank CORBIN, III, Thomas J. FELT
-
Publication number: 20100022935Abstract: A connection of a patient's vascular system to an extracorporeal blood treatment machine is monitored to ensure the patient's safety during a procedure. The procedure may be hemodialysis, apheresis, plasmapheresis, a coronary by-pass operation, or other procedure. To ensure safe electrical connection, a contact and a return are connected via a conductive connection into the extracorporeal blood circuit. A current is then generated between the contact and the return and is monitored by a non-contact sensor near an access site of the patient. If the current or other quantity related to the current changes significantly, a signal is sent to the machine or a controller to notify a caregiver or a medical professional. The signal may also be sent to immediately stop a blood pump or other component of the machine.Type: ApplicationFiled: July 25, 2008Publication date: January 28, 2010Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.Inventor: Matthew R. Muller
-
Patent number: 7615158Abstract: A method and a device to increase the efficiency of dialysis for the removal from blood of substances that are more or less tightly bound to carriers such as albumin. According to the invention this is accomplished by a simultaneous significant increase of the flow rate of the dialysis fluid and of the area of the membrane that separates the blood from the dialysis fluid, compared to conventional dialysis.Type: GrantFiled: March 25, 2003Date of Patent: November 10, 2009Assignee: Gambro Lundia ABInventors: Jan Sternby, Berit Sternby
-
Publication number: 20090259163Abstract: A blood processing system for collecting and exchanging blood components includes a venous-access device for drawing whole blood from a subject and returning blood components to the subject. The system may also include three lines connecting the venous access device to a blood component separation device and an anticoagulant source. A blood draw line fluidly connects to the venous-access device to the blood component separation device. An anticoagulant line connected to an anticoagulant source, introduces anticoagulant into the drawn whole blood. A return line, fluidly connected to the venous-access device and the blood component separation device, and returns uncollected blood component to the subject. A draw pump, an anticoagulant pump, and a return pump, respectively control the flows through the draw line, anticoagulant line, and the return line. The blood component separation device separates the drawn blood into a first blood component and a second blood component.Type: ApplicationFiled: April 14, 2008Publication date: October 15, 2009Inventors: Etienne Pages, Michael Ragusa
-
Publication number: 20090259164Abstract: A blood processing device for collecting and exchanging blood components includes a venous-access device for drawing whole blood from a subject and returning unused blood components to the subject. The system may also include a blood component separation device that separates the drawn whole blood into a first blood component and a second blood component. The blood component separation device may also be configured to send the second blood component to a second blood component storage container. The system may use a return line that fluidly connects the venous-access device and the blood component separation device to return the first blood component to the subject. The system may also have a first and second pressure sensor located on the return line. The first pressure sensor may be located between the blood component separation device and the venous-access device and may determine a first pressure within the return line.Type: ApplicationFiled: April 14, 2008Publication date: October 15, 2009Inventors: Etienne Pages, Michael Ragusa
-
Patent number: 7585412Abstract: A plasmapheresis and/or ultrafiltration membrane comprises elongated hollow fibers each fiber having an interior lumen extending along the fiber length, the fiber wall having a plurality of zones between the inner and outer wall surfaces, each of the zones having a mass density different than the mass density of an adjacent zone. The fiber wall is characterized by having a lower mass density zone at the inner wall surface and a higher mass density zone at the outer wall surface. The fiber is further characterized by having an average elongation breaking force strength of at least about 0.2 lbs. and an average elongation of at least about 45%.Type: GrantFiled: April 14, 2006Date of Patent: September 8, 2009Assignee: Transvivo, Inc.Inventors: Reynolds G. Gorsuch, Henry Grage, Harold H. Handley, Jr., Harold W. Peters, Jacob C. Kearns
-
Publication number: 20090216173Abstract: The invention relates to membranes for haemodialysis, haemofiltration and/or plasmapheresis formed from substituted or unsubstituted cellulose carbamate having a carbamate nitrogen content in the range between 0.1 and 6%. The invention also relates to a method for manufacturing membranes of this type as well as to their use for blood detoxification within the framework of ultrafiltration, high flux dialysis, haemo-diafiltration and plasmapheresis of the blood.Type: ApplicationFiled: May 12, 2005Publication date: August 27, 2009Inventors: Jürgen Gensrich, Hans-Peter Fink, Gerd Weidel
-
Publication number: 20090209898Abstract: This invention describes a method for pumping or delivering fluids utilizing a flexible vessel subject to controlled pressures within another pressure vessel. The pressure vessel can be sourced with positive and/or negative (e.g., vacuum) pressure.Type: ApplicationFiled: April 21, 2009Publication date: August 20, 2009Applicant: THERAKOS, INC.Inventor: Dennis A. Briggs
-
Patent number: 7572374Abstract: An in-vivo plasmapheresis or in-vivo ultrafiltration membrane comprises a plurality of elongated hollow microporous fibers each fiber having an outer wall, an inner wall and an interior lumen extending along the length thereof and defined by an inner wall surface, and wherein the fiber wall structure is a substantially continuous change in mass density from the outer wall to the inner wall and comprises a continuum of voids bounded by solid frames, the fiber wall having an asymmetrical pore size and asymmetrical mass density between said inner wall surface and the outer wall surface with a higher mass density adjacent to the outer wall and a lower mass density adjacent to said inner wall, and characterized by a nitric oxide donor composition capable of producing or releasing nitric oxide or inducing nitric oxide production or release in-vivo with a blood vessel, distributed on or in the fiber wall.Type: GrantFiled: January 18, 2006Date of Patent: August 11, 2009Assignee: Transvivo, Inc.Inventors: Reynolds G. Gorsuch, Harold H. Handley, Jr., Harold W. Peters, Jacob C. Kearns
-
Publication number: 20090118660Abstract: Method for in-vivo plasmapheresis utilizing a plurality of elongated hollow microporous filter fibers periodically interrupt diffusion of blood plasma from a patient, and, for a selected time, directing backflush fluid into the fibers at a pressure and interval sufficient to cleanse the fiber pores, after which plasma diffusion is resumed. The backflush fluid, preferably a normal saline solution, may contain an anticoagulant such as heparin, citrate or NO donor in suitable concentration for systemic anti-coagulation or for treating the fiber for thromboresistance.Type: ApplicationFiled: January 13, 2009Publication date: May 7, 2009Applicant: Transvivo Inc.Inventors: Reynolds G. Gorsuch, Tommy Gene Cooper, Harold H. Handley, JR., Harold W. Peters
-
Patent number: 7513882Abstract: This invention provides a method for controlling a fluid separation system, preferably a blood apheresis system having a leukocyte reduction chamber. The method utilizes a three-level alarm system. A first-level alarm condition is triggered in response to a pressure drop in the system to less than or equal to a specified system pressure and pauses fluid flow in at least a portion of the system. A second-level alarm condition is triggered in response to a specified number of said pressure drops within a specified period and reduces the flow rate of the fluid in the system. The alarm conditions may also trigger a visible and/or audible alarm. These alarm levels permit flow through the leukocyte reduction chamber to continue when the pressure drop is caused by a non-serious, self-resolving or easily-correctable condition such as misalignment of system components.Type: GrantFiled: September 8, 2006Date of Patent: April 7, 2009Assignee: CaridianBCT, Inc.Inventors: Thomas J. Felt, Marlene Adele Bainbridge
-
Publication number: 20090043237Abstract: Methods, devices and device components are presented for blood processing. Particularly, methods, devices and device components are presented for separating blood into blood components and collecting one or more separated blood components, which reduce the incidence of blood vessel infiltration and enhance donor comfort. In one aspect, the invention provides blood processing methods having a return flow rate which decreases systematically during a return time. In another aspect, the invention provides blood processing methods having a removal flow rate, return flow rate or both which are derived from a subject's total blood volume. In another aspect, the present invention provides blood processing methods wherein the fraction by volume of removed blood corresponding to collected components is selected to optimize blood processing efficiency and enhance the purities of collected blood components.Type: ApplicationFiled: August 7, 2008Publication date: February 12, 2009Applicant: CaridianBCT, Inc.Inventors: Robert W. Langley, Thomas J. Felt, Geert Van Waeg, Marlene Adele Bainbridge
-
Patent number: 7476210Abstract: Method for in-vivo plasmapheresis utilizing a plurality of elongated hollow microporous filter fibers periodically interrupt diffusion of blood plasma from a patient, and, for a selected time, directing backflush fluid into the fibers at a pressure and interval sufficient to cleanse the fiber pores, after which plasma diffusion is resumed. The backflush fluid, preferably a normal saline solution, may contain an anticoagulant such as heparin, citrate or NO donor in suitable concentration for systemic anti-coagulation or for treating the fiber for thromboresistance.Type: GrantFiled: December 29, 2005Date of Patent: January 13, 2009Assignee: Transvivo Inc.Inventors: Reynolds G. Gorsuch, Tommy Gene Cooper, Harold H. Handley, Jr., Harold W. Peters
-
Patent number: 7442546Abstract: A method of immunomodulation by contacting the bodily fluid of a patient with renal tubule cells outside of the kidney.Type: GrantFiled: February 25, 2003Date of Patent: October 28, 2008Assignee: The Regents of the University of MichiganInventor: H. David Humes
-
Patent number: 7326182Abstract: Bio-affinity material containing at least one biologically active saccharide which is covalently bound via at least one spacer to a cross-linked matrix and that the material is autoclaved. Apparatus for contacting body fluids with the bio-affinity material is disclosed.Type: GrantFiled: December 15, 2005Date of Patent: February 5, 2008Assignee: Glycorex Transplantation ABInventor: Kurt G. L. Nilsson
-
Publication number: 20080021364Abstract: A fluidic device that includes a channel and a container that generates a pressure difference in the channel when the container is broken. The container includes a brittle material. The first container (a) defines a space within the first container having a gas pressure that is different from the gas pressure outside of the first container, or (b) includes a first material that is separated from a second material prior to the breaking of the first container. The first and second materials are selected to generate gas upon interaction of the first and second materials.Type: ApplicationFiled: December 19, 2006Publication date: January 24, 2008Applicant: Industrial Technology Research InstituteInventor: Kuo-Yao Weng
-
Patent number: 7314460Abstract: The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extracorporeal body fluid system.Type: GrantFiled: July 6, 2005Date of Patent: January 1, 2008Assignee: XEP MED, Inc.Inventors: Hosheng Tu, Hun-Chi Lin, Yu-An Chang
-
Patent number: 7291269Abstract: A device and method for an extracorporeal blood treatment is described. The device comprising at least one exchanger equipped with at least one first inlet for the blood to be treated, a first fluid outlet and a second fluid outlet, an input line for blood to be treated connected to the first inlet of the exchanger, a blood output line (or venous line) connected to the first outlet of the exchanger, at least one treatment unit comprising at least one first fluid inlet and at least one first fluid outlet, the second outlet of the exchanger being in fluid communication with the first inlet of the treatment unit, where the first outlet from the treatment unit is in fluid communication with the input line and the second outlet of the treatment unit is in fluid communication with a first waste liquid discharge line.Type: GrantFiled: March 17, 2004Date of Patent: November 6, 2007Assignee: Gambro Lundia ABInventors: Jacques Chevallet, Guy Mercier, Hiram Rada, Mehran Monchi
-
Patent number: 7270645Abstract: A method and apparatus for producing blood component products. In one embodiment, a plurality of a predetermined type of blood component is harvested from a source of whole blood. At least two on-line yield determination techniques are utilized to determine the yield for the harvested blood components. One is a predetermined yield prediction technique and the second is a predetermined yield monitoring technique, each of which are individually calibrated in relation to a predetermined off-line yield determination technique. The predetermined yield prediction and monitoring techniques each provide the yield for the harvested blood components and each is then utilized to provide a determined yield. Consequently, when the harvested blood components are packaged the determined yield my be associated therewith, thereby providing a blood component product.Type: GrantFiled: January 26, 2005Date of Patent: September 18, 2007Assignee: Gambro BCT, IncInventors: Robert Warner Langley, Larry Joe Dumont
-
Patent number: 7195711Abstract: An in-vivo plasmapheresis and/or in-vivo ultrafiltration membrane comprises elongated hollow fibers each fiber having an interior lumen extending along the fiber length, the fiber wall having a plurality of zones between the inner and outer wall surfaces, each of the zones having a mass density different than the mass density of an adjacent zone. The fiber wall is characterized by having a lower mass density zone at the inner wall surface and a higher mass density zone at the outer wall surface. The fiber is further characterized by having an average elongation breaking force strength of at least about 0.2 lbs. and an average elongation of at least about 45%.Type: GrantFiled: October 6, 2004Date of Patent: March 27, 2007Assignee: Transvivo Inc.Inventors: Reynolds G. Gorsuch, Henry Grage, Harold Handley, Jr., Harold Peters, Jacob C. Kearns
-
Patent number: 7195606Abstract: The invention provides a syringe for preventing anemia resulting from withdrawal of blood from a patient for analysis, the syringe including a cylindrical tube having a nozzle at its lower end to which a needle is attachable; a piston disposed within the tube and apiston handle protruding from the upper end of hte tube; the syringe being further adapted to a be placed in a centrifuge for separating blood drawn from the patient into supernatant plasma component and a packed-cells component, and further comprising means for separating or removing at least a portion of teh plasma, thereby facilitating the injection of the packed-cells back into the patient The invention also provides a method for preventing anemia resulting from the withdrawal of blood from a patient for analysis.Type: GrantFiled: February 19, 2002Date of Patent: March 27, 2007Assignee: ErythroSave Ltd.Inventor: Ben-Ami Ballin
-
Patent number: 7186231Abstract: An object is to provide a blood component collection system capable of collecting a desired blood component of high quality. A blood component collection system 1 comprises a centrifugal separator 20 centrifuging blood into a plurality of components, first line 21 for feeding the blood to the centrifugal separator 20, a second line 22 for releasing the blood component from the centrifugal separator 20, a temporary reservoir bag 26? for temporarily reserving the platelet concentrate, a leukoreduction filter 261 for separating and reducing leukocyte from the platelet concentrate, and a platelet collection bag 26 for reserving the platelet concentrate having passed through the leukoreduction filter 261.Type: GrantFiled: March 19, 2002Date of Patent: March 6, 2007Assignee: Terumo Kabushiki KaishaInventors: Yoshiki Takagi, Shigeyuki Kimura
-
Patent number: 7169547Abstract: A therapeutic product formed from a high concentration of white blood cells having a high degree of cell viability. The white blood cells are sequestered from their normal population presence in whole blood by placing the blood into a container and preventing coagulation of the blood, separating the blood into two components, one of which is extremely rich in white blood cells through the use of a reagent and centrifugation, sequestering the white cell concentration, and freezing the white cells.Type: GrantFiled: May 15, 2001Date of Patent: January 30, 2007Assignee: New York Blood Center, Inc.Inventors: Pablo Rubinstein, Philip Henry Coelho, Cladd E. Stevens
-
Patent number: 7115205Abstract: A system for automatically collecting and separating whole blood into its components is described. The system includes a console, which contains all motors, pumps, sensors, valves and control circuitry, and a unique disposable set that includes a cassette supporting a centrifuge with an improved design, pump interfaces with an improved design, component and solution bags, and tubing. Various processes are implemented using a specific disposable set for each process which allows automatic identification of the process to be performed the console.Type: GrantFiled: July 14, 2004Date of Patent: October 3, 2006Assignee: Mission Medical, Inc.Inventors: Thomas C. Robinson, Thomas P. Robinson, Richard D'Elia, Thomas Sahines, Paul Eibe
-
Patent number: 7108672Abstract: An extracorporeal blood processing system is disclosed which includes a variety of novel components and which may be operated in accordance with a variety of novel methodologies. For instance, the system includes a graphical operator interface which directs the operator through various aspects of the apheresis procedure. Moreover, the system also includes a variety of features relating to loading a blood processing vessel into a blood processing channel and removing the same after completion of the procedure. Furthermore, the system also includes a variety of features relating to utilizing a blood priming of at least portions of the apheresis system in preparation for the procedure. In addition, the system includes a variety of features enhancing the performance of the apheresis system, including the interrelationship between the blood processing vessel and the blood processing channel and the utilization of high packing factors for the procedure.Type: GrantFiled: August 6, 2004Date of Patent: September 19, 2006Assignee: Gambro IncInventors: Chad C Steele, Marlene Adele Bainbridge, Denise C Garrison, Terry R Wahl
-
Patent number: 7037428Abstract: A system for automatically processing blood components is described. The system includes a console, which contains all motors, pumps, sensors, valves and control circuitry, and a unique disposable set that includes a cassette supporting a centrifuge with an improved design, pump interfaces with an improved design, component and solution bags, and tubing. Various processes are implemented using a specific disposable set for each process which allows automatic identification of the process to be performed the console.Type: GrantFiled: April 18, 2003Date of Patent: May 2, 2006Assignee: Mission Medical, Inc.Inventors: Thomas C. Robinson, Thomas P. Robinson, Richard D'Elia, Paul Eibe, Thomas Sahines
-
Patent number: 7025881Abstract: The invention relates to a filter arrangement for the separation of blood into plasma and cellular components, comprising at least one filter element with an inlet line and an outlet chamber in a closed housing, separated by a fine pore membrane. The inlet chamber is connected to an inlet line for donor blood an dan outlet line for cellular components and the outlet chamber is connected to an outlet line for plasma. The arrangement further comprises a device for the production of a backpressure in the filter element, whereby the fine pore membrane is in the form of a U-shaped bundle of n=650 hollow fibers of the type Micro PES-TF 10 from Akzo Faser AG, the ends of which are fixed in an air-tight and germ-tight manner to an aperture plate which seals the open end region of the housing, which is open at just one end, in an air-tight and germ-tight manner.Type: GrantFiled: May 23, 2001Date of Patent: April 11, 2006Assignee: Heim Medizintechnik GmbHInventor: Gerd H. Heim
-
Patent number: 7001513Abstract: A biological fluid processing device includes a multiple biological fraction container enclosing a liquid biological fraction. A rigid cassette contains at least one biological fluid processing chamber. A biological fluid processing chamber includes an affinity media chamber, a gel media chamber, a concentration chamber and a collection chamber. Tubing in fluid communication with the container and the biological fluid processing chamber is selectively compressed to provide a valving function. A programmable instrument receives the cassette and regulates the valving to control the flow of the biological fluid fraction through the device.Type: GrantFiled: August 6, 2003Date of Patent: February 21, 2006Assignee: NuVue Technologies, Inc.Inventor: Craig J. Bell
-
Patent number: 6969367Abstract: The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extracorporeal body fluid system.Type: GrantFiled: November 24, 2003Date of Patent: November 29, 2005Assignee: XEPMED, Inc.Inventors: Hosheng Tu, Hun-Chi Lin, Yu-An Chang
-
Patent number: 6960178Abstract: An apparatus and methods for enhanced plasmapheresis comprising a filter membrane under an orbital motion or movement that has optimal local shear forces and maximum plasma flow output. The methods for biological separation and therapies comprise platelet collection, viral particle removal, cell washing and processing for stem cell selection, bone marrow purging, red blood cell collection, auto-transfusion, auto-immune disease treatment, selective macro-molecule removal, toxin removal, LDL removal, extracorporeal plasma delipidation, and the like.Type: GrantFiled: July 15, 2002Date of Patent: November 1, 2005Assignee: XEPMED, Inc.Inventors: Yu-An Chang, Daniel Duff, Hosheng Tu
-
Patent number: 6949078Abstract: Segmental edema is treated by inserting a plasma extraction filter device in a major vein of a body segment or servicing the body segment containing the edemic tissues, and inserting a return catheter in a major artery of the body segment affected or feeding the body segment from which plasma is extracted. Blood plasma and plasma proteins extracted from the edemic body segment through the plasma extraction filter fluids are directed to an ultrafiltration apparatus where plasma water is separated from the plasma proteins. Plasma proteins are returned to the body segment from which the plasma was extracted via the return catheter in the major artery of the subject body segment.Type: GrantFiled: January 31, 2003Date of Patent: September 27, 2005Assignee: Transvivo, Inc.Inventors: Reynolds G. Gorsuch, Kris Venkat
-
Patent number: 6945948Abstract: Methods and apparatus particularly involving the separation of blood into blood components and the collection of such components are disclosed. In one aspect, an extra-corporeal method for the collection of plasma and red blood cells is provided, wherein the collection of plasma and red blood cells may occur simultaneously or subsequently utilizing the same dual stage blood processing vessel. The flow of blood to the blood processing vessel and return of uncollected blood components may be provided via a single needle, wherein blood is removed from and returned to a donor/patient during alternating blood removal and blood return submodes. Platelet separation and collection options are also described. In either case, prior to red blood cell collection, a set-up phase may be carried out to set a predetermined hematocrit and AC ratio. Replacement fluid delivery may optionally also be provided either substantially continuously during any collection phase(s) and/or in a bolus mode.Type: GrantFiled: April 20, 2004Date of Patent: September 20, 2005Assignee: Gambro, Inc.Inventors: Marlene Bainbridge, Muriel Keller, Timothy M. Gordon, Michael J. McAteer, Scott D. Butzke
-
Patent number: 6899692Abstract: A filter device for being implanted in a blood vessel for carrying out in-vivo plasma separation comprises one or more elongated hollow tubes and a plurality of elongated hollow microporous fibers, each fiber having a first and second end secured to one or more of the elongated hollow tubes with the interior lumen of each of the fibers communicating with the interior of the one or more of the hollow tubes, and wherein the fiber wall has a higher mass density zone adjacent to the outer wall surface and a lower mass density zone adjacent to the inner wall surface.Type: GrantFiled: October 17, 2001Date of Patent: May 31, 2005Assignee: Transvivo, Inc.Inventors: Reynolds G. Gorsuch, Harold W. Peters, Harold H. Handley, Jr.
-
Patent number: 6893412Abstract: A platelet collecting apparatus 1 comprises a centrifugal separator 20 possessing a rotatable rotor 142; a first line 21 for allowing the flow of the blood entering the centrifugal separator 20; a second line 22 for allowing the flow of the blood emanating from the centrifugal separator, a plasma collecting bag 25 connected to the first line 21 and the second line 22 so as to collect the plasma emanating from the centrifugal separator 20 and return the collected plasma to the centrifugal separator 20, a platelet collecting bag 26 connected to the second line 22 so as to collect the platelets emanating from the centrifugal separator 20, a blood delivering pump 11 disposed in the first line 21, and a controller 13 for controlling the operation of the rotor of the centrifugal separator 20 and the operation of the blood delivering pump 11.Type: GrantFiled: November 28, 2001Date of Patent: May 17, 2005Assignee: Terumo Kabushiki KaishaInventors: Noboru Saito, Takeshi Udagawa, Kunio Horiuchi
-
Patent number: 6869412Abstract: Plasma fluid removal is needed in a variety of clinical conditions including congestive heart failure and moderate renal insufficiency. In order to avoid the problems inherent in extracorporeal ultrafiltration methods, the present invention removes fluid using an intravascular or intracorporeal dual-lumen catheter. Plasma fluid is driven across a semipermeable membrane, as in an in vivo vascular catheter. Suboptimal intracatheter flow, luminal collapse, erratic high transmembrane flow with nonhomogenous caking and clotting of the external catheter surface are all avoided by inducing pressure gradients across the wall by means of osmotic forces instead of negative pressures induced by hydraulic pumps. Osmotically induced fluid flow would tend to keep the lumena slightly distended and thereby simplify the fluid delivery systems.Type: GrantFiled: November 13, 2001Date of Patent: March 22, 2005Inventor: Edward Allan Ross
-
Publication number: 20040249332Abstract: Methods and apparatus particularly involving the separation of blood into blood components and the collection of such components are disclosed. In one aspect, an extra-corporeal method for the collection of plasma and red blood cells is provided, wherein the collection of plasma and red blood cells may occur simultaneously or subsequently utilizing the same dual stage blood processing vessel. The flow of blood to the blood processing vessel and return of uncollected blood components may be provided via a single needle, wherein blood is removed from and returned to a donor/patient during alternating blood removal and blood return submodes. Platelet separation and collection options are also described. In either case, prior to red blood cell collection, a set-up phase may be carried out to set a predetermined hematocrit and AC ratio. Replacement fluid delivery may optionally also be provided either substantially continuously during any collection phase(s) and/or in a bolus mode.Type: ApplicationFiled: April 20, 2004Publication date: December 9, 2004Applicant: GAMBRO, INC.Inventors: Marlene Bainbridge, Muriel Keller, Timothy M. Gordon, Michael J. McAteer, Scott D. Butzke
-
Publication number: 20040236262Abstract: A double syringe delivery system is disclosed for holding a pair of syringes in a manner so as to accommodate the simultaneous activation of the plunger of each syringe in order to effect simultaneous delivery of the contents of each syringe. The delivery system includes a delivery mechanism for delivering the contents of both syringes to a site of application. The delivery system further includes a support member that is positioned between the two syringe bodies. The elongated support member has resilient, C-shaped clamps on one end of the support member. The clamps are designed to be removably clamped onto the applicator so that the syringe barrels will be held together in a parallel manner. The elongated support member further comprises finger grips. A plunger connects the two syringe plungers so that they can also be simultaneously activated.Type: ApplicationFiled: June 24, 2004Publication date: November 25, 2004Inventors: Kevin D. McIntosh, Richard M. Albrecht
-
Patent number: 6802971Abstract: An in-vivo plasmapheresis and/or in-vivo ultrafiltration membrane comprises a plurality of elongated hollow fibers each fiber having an interior lumen extending along the fiber length, the fiber wall having a plurality of zones between the inner and outer wall surfaces, each of the zones having a mass density different than the mass density of an adjacent zone. The fiber wall is characterized by having a lower mass density zone at the inner wall surface and a higher mass density zone at the outer wall surface.Type: GrantFiled: September 17, 2003Date of Patent: October 12, 2004Assignee: Transvivo Inc.Inventors: Reynolds Gorsuch, Henry Grage